- Home
- TIL vs OPBK Comparison
TIL vs OPBK Comparison
Compare TIL & OPBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- OPBK
- Stock Information
- Founded
- TIL 2018
- OPBK 2005
- Country
- TIL United States
- OPBK United States
- Employees
- TIL N/A
- OPBK N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- OPBK Major Banks
- Sector
- TIL Health Care
- OPBK Finance
- Exchange
- TIL Nasdaq
- OPBK Nasdaq
- Market Cap
- TIL 230.1M
- OPBK 176.4M
- IPO Year
- TIL 2021
- OPBK 2018
- Fundamental
- Price
- TIL $21.92
- OPBK $13.63
- Analyst Decision
- TIL Buy
- OPBK Hold
- Analyst Count
- TIL 5
- OPBK 1
- Target Price
- TIL $119.00
- OPBK $18.00
- AVG Volume (30 Days)
- TIL 345.1K
- OPBK 157.5K
- Earning Date
- TIL 08-12-2025
- OPBK 07-24-2025
- Dividend Yield
- TIL N/A
- OPBK 3.54%
- EPS Growth
- TIL N/A
- OPBK 0.92
- EPS
- TIL N/A
- OPBK 1.42
- Revenue
- TIL N/A
- OPBK $81,356,000.00
- Revenue This Year
- TIL N/A
- OPBK $19.87
- Revenue Next Year
- TIL N/A
- OPBK $10.60
- P/E Ratio
- TIL N/A
- OPBK $9.56
- Revenue Growth
- TIL N/A
- OPBK 4.15
- 52 Week Low
- TIL $9.62
- OPBK $9.42
- 52 Week High
- TIL $92.00
- OPBK $18.57
- Technical
- Relative Strength Index (RSI)
- TIL 40.10
- OPBK 63.27
- Support Level
- TIL $25.80
- OPBK $11.52
- Resistance Level
- TIL $23.30
- OPBK $13.19
- Average True Range (ATR)
- TIL 3.63
- OPBK 0.36
- MACD
- TIL -1.84
- OPBK 0.14
- Stochastic Oscillator
- TIL 1.91
- OPBK 95.21
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.